The Genome as Commons
By Tom Athanasiou and Marcy Darnovsky,
WorldWatch
| 07. 01. 2002
Through all the trials and tribulations of human history what binds us in the end is our common humanity
July/August 2002
The atmosphere. The oceans and fresh waters. The land itself, and the fruits and grains our forebears bred and cultivated upon it. The broadcast spectrum. The attention spans of our children.
Does such a list adequately evoke "the commons," and the stakes we face in trying to save it—both for itself and as the foundation of our common future? Or must we add yet another, more shocking example? Perhaps we must put the human genome itself on this endangered commons list, and note that if this genetic commons too is lost to partition and privatization, if it too becomes the privilege of the affluent, then none of us on either side of the divide can be sure of retaining the "humanity" we like to think we've achieved.
The biotech boosters, of course, don't see things this way. Many of them insist that any conceivable application of human genetic engineering is essential to medical progress, and that the possibilities, no matter how speculative, trump all other considerations. Thus they shrug off the likely outcome of embryo cloning—that it will...
Related Articles
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Roni Caryn Rabin, The New York Times | 04.03.2024
By Hilary Brueck, Business Insider | 03.23.2024
"OpenAI Co-Founder & CEO Sam Altman speaks onstage during TechCrunch Disrupt San Francisco 2019 at Moscone Convention Center on October 03, 2019 in San Francisco, California (Photo by Steve Jennings/Getty Images for TechCrunch)" by TechCrunch is licensed under CC by...
By Rob Stein, NPR | 03.21.2024
For the first time, surgeons have transplanted a kidney from a genetically modified pig into a living person, doctors in Boston said Thursday.
Richard Slayman, 62, of Weymouth, Mass., who is suffering from end-stage kidney disease, received the organ...